HomeInsightsStock Comparison

Brawn Biotech Ltd vs Panacea Biotec Ltd Stock Comparison

Brawn Biotech Ltd vs Panacea Biotec Ltd Stock Comparison

Last Updated on: May 12, 2025

Key Highlights

  • The Latest Trading Price of Brawn Biotech Ltd is ₹ 16.25 as of 08 May 15:30.
  • The P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Market Cap of Brawn Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Panacea Biotec Ltd changed from ₹ 670.7 crore on March 2020 to ₹ 742.97 crore on March 2024 . This represents a CAGR of 2.07% over 5 years.
  • The revenue of Brawn Biotech Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Panacea Biotec Ltd for the Dec '24 is ₹ 169.88 crore as compare to the Sep '24 revenue of ₹ 154.77 crore. This represent the growth of 9.76%.
  • The ebitda of Brawn Biotech Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Panacea Biotec Ltd for the Dec '24 is ₹ 14.35 crore as compare to the Sep '24 ebitda of ₹ 14.42 crore. This represent the decline of -0.49%.
  • The net profit of Brawn Biotech Ltd changed from ₹ -0.04 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Panacea Biotec Ltd changed from ₹ 10.98 crore to ₹ 4.44 crore over 7 quarters. This represents a CAGR of -40.39% .
  • The Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Brawn Biotech Ltd

  • Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
  • Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
  • Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
  • Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Brawn Biotech Ltd News Hub

News

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February ...

Read more

05 Feb 2025 12:58

News

Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

11 Nov 2024 12:21

News

Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be ...

Read more

05 Sep 2024 15:14

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

12 Aug 2024 14:29

News

Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2024 ...

Read more

28 May 2024 14:18

News

Brawn Biotech announces board meeting date

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 2024 13:37

Panacea Biotec Ltd News Hub

News

Panacea Biotec to announce Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

01 Feb 2025 10:27

News

Panacea Biotec Pharma launches 'NikoMom' brand of baby diapers and wipes

Panacea Biotec announced that the company's wholly owned subsidiary, Panacea Biotec Pharma...

Read more

03 Jan 2025 15:24

News

Panacea Biotec announces investment in Panacea Biotec Inc.

Panacea Biotec announced that the company's material subsidiary, Panacea Biotec Pharma (PB...

Read more

28 Dec 2024 14:00

News

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

The company will supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa ...

Read more

26 Dec 2024 10:30

News

Panacea Biotec wins order of Rs 127 cr from UNICEF

Panacea Biotec has received a Letter of Award from UNICEF for supply of 115 million doses ...

Read more

24 Dec 2024 17:54

News

Panacea Biotec to hold board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 November...

Read more

31 Oct 2024 12:09

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Brawn Biotech Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Brawn Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Brawn Biotech Ltd and Panacea Biotec Ltd

Which company has a larger market capitalization, Brawn Biotech Ltd or Panacea Biotec Ltd?

Market cap of Brawn Biotech Ltd is 5 Cr while Market cap of Panacea Biotec Ltd is 3,004 Cr

What are the key factors driving the stock performance of Brawn Biotech Ltd and Panacea Biotec Ltd?

The stock performance of Brawn Biotech Ltd and Panacea Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brawn Biotech Ltd and Panacea Biotec Ltd?

As of May 12, 2025, the Brawn Biotech Ltd stock price is INR ₹19.0. On the other hand, Panacea Biotec Ltd stock price is INR ₹490.6.

How do dividend payouts of Brawn Biotech Ltd and Panacea Biotec Ltd compare?

To compare the dividend payouts of Brawn Biotech Ltd and Panacea Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions